Zusammenfassung: Die medizinische Literatur, insbesondere sekund\u00e4re Quellen wie Reviews, Metaanalysen und Briefe an Herausgeber werden offensichtlich durch Ghost management und Ghostwriting stark von pharmazeutischen Unternehmen (pU) manipuliert und dadurch als Marketinginstrument verwendet. Professionelle Ghostwriting-Agenturen werden beauftragt, Artikel mit positivem Fazit zum Nutzen neuer Arzneimittel zu verfassen. Als (Gast)-Autoren werden dabei renommierte \u201eKey opinion leaders\u201d genannt. […]<\/p>\n","protected":false},"excerpt":{"rendered":"
Zusammenfassung: Die medizinische Literatur, insbesondere sekund\u00e4re Quellen wie Reviews, Metaanalysen und Briefe an Herausgeber werden offensichtlich durch Ghost management und Ghostwriting stark von pharmazeutischen Unternehmen (pU) manipuliert und dadurch als Marketinginstrument verwendet. Professionelle Ghostwriting-Agenturen werden beauftragt, Artikel mit positivem Fazit zum Nutzen neuer Arzneimittel zu verfassen. Als (Gast)-Autoren werden dabei renommierte \u201eKey opinion leaders\u201d genannt. […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[255,4419,1355,1360,4420,236,3736,4425,4426,3737,358,363,360,364,4423,4422,4421,3262,357,2229,257,362,922,843,846,359,4424,3370,4416,1858,381,378,375,2579,377,1409,4417,4418,1561,2581,1350],"class_list":["post-2215","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-arzneimittel","tag-autoren","tag-cox-2-hemmer","tag-coxibe","tag-designwrite","tag-gabapentin","tag-gastautoren","tag-ghost-management","tag-ghostmanagement","tag-ghostwriter","tag-het","tag-hormonersatz-therapie","tag-hormonersatztherapie","tag-hrt","tag-information","tag-international-society-for-medical-publication-planning-association","tag-ismpp","tag-key-opinion-leaders","tag-klimakterium","tag-marketing","tag-medikamente","tag-menopause","tag-paroxetin","tag-pharmaindustrie","tag-pharmazeutische-unternehmer","tag-postmenopause","tag-pre-launch","tag-publikationen","tag-publikationsplanung","tag-rofecoxib","tag-selektive-serotonin-wiederaufnahme-hemmer","tag-serotonin-wiederaufnahme-hemmer","tag-sertralin","tag-sonderdrucke","tag-ssri","tag-studien","tag-the-international-publication-planning-association","tag-tippa","tag-werbung","tag-zeitschriften","tag-zyklooxygenase-2-hemmer"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/2215","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=2215"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/2215\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=2215"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=2215"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=2215"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}